Cargando…
Case report: passive transfer of hepatitis B antibodies from intravenous immunoglobulin
BACKGROUND: Prior to initiating immunosuppressive therapy in the treatment of autoimmune inflammatory conditions, it is a requirement to screen for certain viral serology, including hepatitis B (HBV). A positive result may indicate the need for antiviral therapy, or contraindicate immunosuppression...
Autores principales: | Parker, Simon, Gil, Eliza, Hewitt, Patricia, Ward, Katherine, Reyal, Yasmin, Wilson, Sasha, Manson, Jessica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937526/ https://www.ncbi.nlm.nih.gov/pubmed/24559411 http://dx.doi.org/10.1186/1471-2334-14-99 |
Ejemplares similares
-
Antibodies against Hepatitis A and Hepatitis B Virus in Intravenous Immunoglobulin Products
por: Lee, Soyoung, et al.
Publicado: (2016) -
Intravenous immunoglobulin for infectious diseases: back to the pre-antibiotic and passive prophylaxis era?
por: Bayry, Jagadeesh, et al.
Publicado: (2004) -
Misleading hepatitis B testing in the setting of intravenous immunoglobulin
por: Ilboudo, Christelle M, et al.
Publicado: (2013) -
Antifungal antibodies present in intravenous immunoglobulin derived from China
por: Wang, Yanfang, et al.
Publicado: (2023) -
Pneumococcal Antibody Titers: A Comparison of Patients Receiving Intravenous Immunoglobulin Versus Subcutaneous Immunoglobulin
por: Abghari, Pamella F., et al.
Publicado: (2017)